Treatment and outcomes in patients with myocardial infarction treated with acute β-blocker therapy: results from the American College of Cardiology's NCDR(®).

No abstract is available for this paper.

• Publication year

  2011

• Venue

  American Heart Journal

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ahj.2011.01.006PMID 21570515
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation

  2012cited by this paper
• How little we know: the search for a simple answer on acute beta-blocker use in the management of acute coronary syndrome.

  2010cited by this paper
• A Call to ACTION (Acute Coronary Treatment and Intervention Outcomes Network): A National Effort to Promote Timely Clinical Feedback and Support Continuous Quality Improvement for Acute Myocardial Infarction

  2009cited by this paper
• Do beta-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis.

  2008cited by this paper
• 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2008cited by this paper
• 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2008cited by this paper
• Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology.

  2008cited by this paper
• Do β-blockers reduce short-term mortality following acute myocardial infarction? A systematic review and meta-analysis

  2008cited by this paper
• ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-Elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patie

  2007cited by this paper
• Application of the Thrombolysis in Myocardial Infarction risk index in non-ST-segment elevation myocardial infarction: evaluation of patients in the National Registry of Myocardial Infarction.

  2006cited by this paper
• ACC/AHA clinical performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures on ST-Elevation and Non-ST-El

  2006cited by this paper
• ACC/AHA 2008 performance measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for ST-Elevation and Non-ST-Eleva

  2006cited by this paper
• Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.

  2005cited by this paper
• Influence of clinical trial enrollment on the quality of care and outcomes for patients with non-ST-segment elevation acute coronary syndromes.

  2005cited by this paper
• Expert consensus document on beta-adrenergic receptor blockers.

  2004cited by this paper
• Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndrome.

  2004cited by this paper
• ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1999 Guidelines for the Management of Patients Wi

  2004cited by this paper
• HLA-MATCHING AND PRETRANSPLANT BLOOD TRANSFUSIONS IN CADAVERIC RENAL TRANSPLANTATION—A CHANGING PICTURE WITH CYCLOSPORIN

  2003cited by this paper
• Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators.

  2000cited by this paper
• ACC/AHA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction: executive summary and recommendations.

  2000cited by this paper
• β Blockade after myocardial infarction: systematic review and meta regression analysis

  1999cited by this paper
• beta Blockade after myocardial infarction: systematic review and meta regression analysis.

  1999cited by this paper
• Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators.

  1995cited by this paper
• Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy.

  1993cited by this paper
• Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.

  1991cited by this paper
• Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction.

  1988cited by this paper
• Beta-adrenergic blockade in acute myocardial infarction: a haemodynamic and radionuclide study.

  1987cited by this paper
• Longitudinal data analysis using generalized linear models

  1986cited by this paper
• Beta blockade during and after myocardial infarction: an overview of the randomized trials.

  1985cited by this paper
• Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.

  1985cited by this paper
• Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.

  1983cited by this paper
• Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: current concepts.

  1983cited by this paper

• National Heart Foundation of Australia & Cardiac Society of Australia and New Zealand: Comprehensive Australian Clinical Guideline for Diagnosing and Managing Acute Coronary Syndromes 2025.

  2025cites this paper
• Early prediction of shock in intensive care unit patients by machine learning using discrete electronic health record data.

  2025cites this paper
• 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cites this paper
• 2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

  2025cites this paper
• The Role of Infarct Border Zone Remodelling in Ventricular Arrhythmias: Bridging Basic Research and Clinical Applications

  2025cites this paper
• Pharmacological Approach for Symptomatic Nonsustained Ventricular Tachycardia

  2024cites this paper
• Predicting the unpredictable: a novel application of artificial intelligence in the cardiac intensive care unit.

  2024cites this paper
• Beta-blockers in cardiac arrhythmias–Clinical pharmacologist’s point of view

  2023cites this paper
• Promising Therapies for Atrial Fibrillation and Ventricular Tachycardia

  2022cites this paper
• Eurasian association of cardiology (EAC) guidelines for the prevention and treatment of ventricular heart rhythm disorders and prevention of sudden cardiac death (2022)

  2022cites this paper
• Non-ST-Elevation Acute Coronary Syndromes

  2022cites this paper
• Comorbid Hypertension Reduces the Risk of Ventricular Arrhythmia in Chronic Heart Failure Patients with Implantable Cardioverter-Defibrillators

  2022cites this paper
• Sudden cardiac death: epidemiology, pathogenesis and management.

  2021cites this paper
• Should We Be Using Upstream Beta-Blocker Therapy for Acute Myocardial Infarction?

  2021cites this paper
• Diretrizes da Sociedade Brasileira de Cardiologia sobre Angina Instável e Infarto Agudo do Miocárdio sem Supradesnível do Segmento ST – 2021

  2021cites this paper
• Eurasian clinical guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndrome (NSTE-ACS)

  2021cites this paper
• Желудочковые нарушения ритма. Желудочковые тахикардии и внезапная сердечная смерть. Клинические рекомендации 2020

  2021cites this paper
• Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines

  2021cites this paper
• How do I diagnose and manage myocardial ischemia in the ICU?

  2020cites this paper
• The prescription retroscope - tools for advocating critical and individualised therapy.

  2020cites this paper
• For Whom the Bell Tolls

  2019cites this paper
• Non-ST Elevation Myocardial Infarction: Diagnosis and Management

  2019cites this paper
• Clinical Outcomes at 2 Years Between Beta-Blockade with ACE Inhibitors or ARBs in Patients with AMI Who Underwent Successful PCI with DES: A Retrospective Analysis of 23,978 Patients in the Korea AMI Registry

  2019cites this paper
• Comments on the 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac

  2019cites this paper
• Anti‐arrhythmic drug therapy in implantable cardioverter‐defibrillator recipients

  2019cites this paper
• Long-term clinical outcome between beta-blocker with ACEI or ARB in patients with NSTEMI who underwent PCI with drug-eluting stents

  2019cites this paper
• Mechano-chronotropic Unloading During the Acute Phase of Myocardial Infarction Markedly Reduces Infarct Size via the Suppression of Myocardial Oxygen Consumption

  2019cites this paper
• Differential Effect of β-Blockers According to Heart Rate in Acute Myocardial Infarction Without Heart Failure or Left Ventricular Systolic Dysfunction: A Cohort Study.

  2019cites this paper
• Nagla srčana smrt

  2019cites this paper
• Optimal treatment of patients with NSTE-ACS in the Dutch health care system

  2018cites this paper
• Non-ST-Segment Acute Coronary Syndromes.

  2018cites this paper
• Optimal treatment of patients with NSTE-ACS in the Dutch health care system

  2018cites this paper
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2018cites this paper
• First 24 h in the management of non-ST segment elevation myocardial infarction

  2018cites this paper
• The Use of Oral Beta-Blockers and Clinical Outcomes in Patients with Non-ST-Segment Elevation Acute Coronary Syndromes: a Long-Term Follow-Up Study

  2018cites this paper
• 2018 Guidelines of the Taiwan Society of Cardiology, Taiwan Society of Emergency Medicine and Taiwan Society of Cardiovascular Interventions for the management of non ST-segment elevation acute coronary syndrome.

  2018cites this paper
• β-Blockers in myocardial infarction and coronary artery disease with a preserved ejection fraction: recommendations, mechanisms, and concerns.

  2018cites this paper
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2018cites this paper
• Primarna prevencija nagle srčane smrti

  2018cites this paper
• Association of Beta-Blockers with Survival on Patients Presenting with ACS Treated with PCI: A Propensity Score Analysis from the BleeMACS Registry

  2018cites this paper
• 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Executive summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cites this paper
• Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing

  2017cites this paper
• Farmakoterapija akutnog infarkta miokarda

  2017cites this paper
• Clinical utility of sympathetic blockade in cardiovascular disease management

  2017cites this paper
• Beta-blockers reduced the risk of cardiac rupture in patients with acute myocardial infarction: A meta-analysis of randomized control trials.

  2017cites this paper
• Análisis del impacto de la revascularización percutánea de lesiones coronarias severas en ramas secundarias

  2017cites this paper
• 2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2017cites this paper
• Comments on the 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2016cites this paper
• 2015 ESC Guidelines for the Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.

  2016cites this paper
• Contribution of Hepatitis B to Long-Term Outcome Among Patients With Acute Myocardial Infarction

  2016cites this paper
• Comentarios a la guía ESC 2015 sobre el tratamiento de pacientes con arritmias ventriculares y prevención de la muerte súbita cardiaca

  2016cites this paper
• An update on management of the patient presenting with non-ST-elevation acute coronary syndromes

  2016cites this paper
• Clinical effect of ticagrelor administered in acute coronary syndrome patients following percutaneous coronary intervention

  2016cites this paper
• Comparison of Early Versus Delayed Oral β Blockers in Acute Coronary Syndromes and Effect on Outcomes.

  2016cites this paper
• ENFOQUE ACTUAL DEL TRATAMIENTO FARMACOLÓGICO DEL SÍNDROME CORONARIO AGUDO SIN ELEVACIÓN DEL SEGMENTO ST. DE LA FISIOPATOLOGÍA AL MANEJO

  2016cites this paper
• Kardiologische Ursachen für Thoraxschmerz

  2016cites this paper
• Association of β-blocker therapy with long-term clinical outcomes in patients with coronary chronic total occlusion

  2016influential citation
• Cardiac Arrhythmias in Patients with Chronic Kidney Disease: Implications of Renal Failure for Antiarrhythmic Drug Therapy.

  2016cites this paper
• From Mars to Venus: Gender Differences in the Management and Outcomes of Acute Coronary Syndromes.

  2016cites this paper
• [2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death].

  2015cites this paper
• Acute coronary syndromes

  2015cites this paper
• National assessment of early β-blocker therapy in patients with acute myocardial infarction in China, 2001-2011: The China Patient-centered Evaluative Assessment of Cardiac Events (PEACE)-Retrospective AMI Study.

  2015cites this paper
• ESC-Leitlinien 2015

  2015cites this paper
• [2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation].

  2015cites this paper
• Prise en charge en urgence des syndromes coronariens aigus non-ST+en 2015

  2015cites this paper
• [ESC guidelines 2015. Non-ST-elevation acute coronary syndrome].

  2015cites this paper
• Comparison of Early-vs-Delayed Oral Beta-Blockers in Acute Coronary Syndromes and Effect on Outcomes Brief title : Beta-Blockers in Acute Coronary Syndromes

  2015cites this paper
• Non-ST-Elevation Myocardial Infarction: Management

  2014cites this paper
• Unstable Angina: Presentation, Diagnosis, and Management

  2014cites this paper
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cites this paper
• 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cites this paper
• 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

  2014cites this paper
• ED administration of thienopyridines in non-ST-segment elevation myocardial infarction: results from the NCDR.

  2013cites this paper
• Benefit of Immediate Beta-Blocker Therapy on Mortality in Patients With ST-Segment Elevation Myocardial Infarction*

  2013cites this paper
• Early β-blockade in acute myocardial infarction

  2013cites this paper
• Changing Practice of Anesthesia 2011 Our on Statins, Beta Blockers and Anti-platelet Agents Aging Patient Populati

  2011cites this paper
• 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC).

  2011cites this paper
• 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: Executive Summary.

  2006cites this paper